METHOXY POLYETHYLENE GLYCOL EPOETIN BETA

N/A

Manufactured by Vifor (International) Inc.

19,964 FDA adverse event reports analyzed

Last updated: 2026-04-14

About METHOXY POLYETHYLENE GLYCOL EPOETIN BETA

METHOXY POLYETHYLENE GLYCOL EPOETIN BETA is a medication tracked in the FDA Adverse Event Reporting System (FAERS), manufactured by Vifor (International) Inc.. The most commonly reported adverse reactions for METHOXY POLYETHYLENE GLYCOL EPOETIN BETA include DRUG HYPERSENSITIVITY, DEATH, DYSPNOEA, NAUSEA, PRURITUS. This page provides a comprehensive breakdown of reported side effects, safety signals, patient demographics, and AI-powered safety analysis for METHOXY POLYETHYLENE GLYCOL EPOETIN BETA.

Top Adverse Reactions

DRUG HYPERSENSITIVITY2,941 reports
DEATH1,563 reports
DYSPNOEA1,098 reports
NAUSEA809 reports
PRURITUS779 reports
VOMITING673 reports
HAEMOGLOBIN DECREASED577 reports
FLUSHING504 reports
ANAEMIA346 reports
FEELING HOT328 reports
UNRESPONSIVE TO STIMULI315 reports
NO ADVERSE EVENT311 reports
DIZZINESS287 reports
RASH276 reports
HYPOTENSION275 reports
BACK PAIN265 reports
APLASIA PURE RED CELL254 reports
HYPERTENSION253 reports
CHEST PAIN243 reports
MALAISE241 reports
ERYTHEMA230 reports
HEADACHE230 reports
PNEUMONIA227 reports
URTICARIA216 reports
INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION197 reports
BLOOD PRESSURE INCREASED196 reports
HYPERHIDROSIS185 reports
DIARRHOEA181 reports
CARDIAC FAILURE173 reports
BLOOD PRESSURE DECREASED172 reports
PAIN157 reports
LOSS OF CONSCIOUSNESS154 reports
RENAL FAILURE147 reports
CARDIAC ARREST140 reports
ASTHENIA139 reports
CHEST DISCOMFORT136 reports
OFF LABEL USE127 reports
FATIGUE126 reports
FALL123 reports
SEPSIS123 reports
ABDOMINAL PAIN122 reports
HYPERSENSITIVITY120 reports
PYREXIA117 reports
RENAL IMPAIRMENT117 reports
DRUG INEFFECTIVE115 reports
BLOOD CREATININE INCREASED114 reports
HEART RATE INCREASED114 reports
HAEMOGLOBIN INCREASED103 reports
CARDIO RESPIRATORY ARREST97 reports
CHRONIC KIDNEY DISEASE97 reports
SERUM FERRITIN INCREASED93 reports
SEIZURE92 reports
BLOOD UREA INCREASED90 reports
MYOCARDIAL INFARCTION90 reports
PLATELET COUNT DECREASED89 reports
TACHYCARDIA89 reports
FEELING ABNORMAL84 reports
PULSE ABSENT84 reports
BLOOD IRON DECREASED83 reports
ANAPHYLACTIC REACTION80 reports
ANXIETY77 reports
COUGH77 reports
INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION75 reports
CEREBROVASCULAR ACCIDENT74 reports
DECREASED APPETITE72 reports
INFECTION72 reports
HAEMATOCRIT DECREASED69 reports
GENERAL PHYSICAL HEALTH DETERIORATION68 reports
ACUTE KIDNEY INJURY67 reports
DIALYSIS65 reports
GASTROINTESTINAL HAEMORRHAGE64 reports
THROAT TIGHTNESS64 reports
ARRHYTHMIA58 reports
HYPERKALAEMIA58 reports
PALPITATIONS57 reports
MARASMUS56 reports
URINARY TRACT INFECTION55 reports
ACUTE MYOCARDIAL INFARCTION54 reports
PALLOR53 reports
PLEURAL EFFUSION53 reports
CONDITION AGGRAVATED52 reports
RESPIRATORY FAILURE52 reports
DISEASE PROGRESSION51 reports
HOSPITALISATION51 reports
SYNCOPE51 reports
CARDIAC FAILURE CONGESTIVE50 reports
MYELODYSPLASTIC SYNDROME50 reports
RESPIRATORY DISTRESS50 reports
THROMBOCYTOPENIA50 reports
HAEMORRHAGE49 reports
PULMONARY OEDEMA48 reports
RED BLOOD CELL COUNT DECREASED48 reports
ATRIAL FIBRILLATION47 reports
PARAESTHESIA47 reports
C REACTIVE PROTEIN INCREASED46 reports
MEDICATION ERROR46 reports
NEPHROGENIC ANAEMIA46 reports
CARDIAC DISORDER45 reports
PAIN IN EXTREMITY45 reports
VISION BLURRED45 reports

Report Outcomes

Out of 10,838 classified reports for METHOXY POLYETHYLENE GLYCOL EPOETIN BETA:

Serious 71.5%Non-Serious 28.5%

The FDA classifies an adverse event as “serious” if it results in death, hospitalization, disability, congenital anomaly, or requires intervention to prevent permanent damage.

Demographics Breakdown

Reports by Sex

Male5,175 (50.0%)
Female5,084 (49.1%)
Unknown92 (0.9%)

Reports by Age

Age 62185 reports
Age 72183 reports
Age 65182 reports
Age 66181 reports
Age 69179 reports
Age 60176 reports
Age 70175 reports
Age 68173 reports
Age 63172 reports
Age 61171 reports
Age 64169 reports
Age 67163 reports
Age 76162 reports
Age 58161 reports
Age 71161 reports
Age 74161 reports
Age 75161 reports
Age 57156 reports
Age 80154 reports
Age 53152 reports

Demographics reflect voluntary FDA adverse event reporting patterns and may not represent the full patient population.

Frequently Asked Questions

How many FDA adverse event reports are associated with METHOXY POLYETHYLENE GLYCOL EPOETIN BETA?

This profile reflects 19,964 FDA FAERS reports that mention METHOXY POLYETHYLENE GLYCOL EPOETIN BETA. Reporting is voluntary and does not prove that the drug caused any listed event.

Which adverse reactions are most often listed for METHOXY POLYETHYLENE GLYCOL EPOETIN BETA?

Frequently reported terms in FAERS include DRUG HYPERSENSITIVITY, DEATH, DYSPNOEA, NAUSEA, PRURITUS, VOMITING. Rankings reflect reporting volume in this dataset, not confirmed side effect rates in the general population.

Who manufactures METHOXY POLYETHYLENE GLYCOL EPOETIN BETA?

Labeling and FAERS entries often list Vifor (International) Inc. in connection with METHOXY POLYETHYLENE GLYCOL EPOETIN BETA. Always verify the specific product and NDC with your pharmacist.

Important Disclaimer: This content is generated by AI analysis of FDA adverse event reports and is provided for informational purposes only. It is not medical advice. Adverse event reports submitted to the FDA do not prove that a medication caused the reported side effect. Always consult your healthcare provider before starting, stopping, or changing any medication. If you experience a serious side effect, contact your doctor or call 911 immediately.